ReviewCMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne2004
Ovarian cancer screening.
Review in CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne, 2004. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 8 papers.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
8 citing papers in PubMed.
- Biomarker testing for ovarian cancer: clinical utility of multiplex assays.Molecular diagnosis & therapy · 2013Review
- Identification of O-glycosylated proteins that are aberrantly excreted in the urine of patients with early stage ovarian cancer.International journal of molecular sciences · 2013Article
- Protein biomarkers of ovarian cancer: the forest and the trees.Future oncology (London, England) · 2012Review
- Native human autoantibodies targeting GIPC1 identify differential expression in malignant tumors of the breast and ovary.BMC cancer · 2008Article
- No efficacy of annual gynaecological screening in BRCA1/2 mutation carriers; an observational follow-up study.British journal of cancer · 2007Article
- Ovarian cancer screening.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005Article
- Ovarian cancer screening.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2005Article
- Osteopontin as a Tumor Marker in Ovarian Cancer.Journal of mid-life healthArticle
Corrections and comments
- Commented on by
- Commented on by
Authors and funding
1 author.
Funding
Abstract
PubMed holds no abstract for this paper.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.